HOME >> BIOLOGY >> NEWS
HPV testing could be future strategy for primary screening for cervical cancer

Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV.

HPV testing (by genetic analysis) of cervical smears is known to be more sensitive than conventional cytology for detecting pre-malignant cervical cells called high-grade cervical intraepithelial neoplasia (CIN2/CIN3); however HPV testing is less specific than cytology (ie. it produces more 'false-positive' results). HPV testing as a primary screening approach is only feasible if appropriate management is given to women who are HPV-positive with negative or borderline cytology results.

The HART (HPV in Addition to Routine Testing) study was led by Jack Cuzick and colleagues from Cancer Research UK. Around 11,000 women aged 30-60 years from 161 GP practices in 5 UK regions participated in the study between 1998 and 2001. Women with borderline cytology and women positive for high-risk HPV with negative cytology were randomised to immediate colposcopy (detailed examination of the cervix) or to surveillance by repeat HPV testing, cytology, and colposcopy at 12 months.

HPV testing was more sensitive than borderline or worse cytology (97% compared with 77%) but slightly less specific (93% compared with 96%) for detecting malignant cells. Surveillance at 12 months was as effective as immediate colposcopy for women with minimal abnormalities, i.e., those women with either borderline cytology results (regardless of HPV status) or who were HPV positive but had negative cytology results.

Jack Cuzick comments: "HPV testing could be used for primary screening in women older than 30 years, with cytology used to triage HPV-positive women. HPV-positive women with normal or borderline cytology (about 6% of screened women) could be managed by repeat testing after 12 mon
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-Dec-2003


Page: 1 2

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Nucleic acid-amplification testing further safeguards nations blood supply
3. Clinical judgement still counts strongly alongside genetic testing
4. Genetic testing of embryos to pick savior sibling OK with most Americans
5. Annual bioethics forum to explore genetic testing
6. New toxicity test could cut animal testing
7. Revised guidelines published for testing for hereditary type of colorectal cancer
8. Study calls for end to age thresholds for prenatal genetic testing
9. Genetic testing of embryos
10. High-risk women welcome genetic testing for breast cancer gene
11. Biomedical scientist testing nanoparticles as early cancer detection agent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings ... TN, from December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an ... the treatment continuum – from the consultation, to surgical planning, and into the ...
(Date:12/5/2018)... ... December 03, 2018 , ... ... MD, PhD, assistant professor in the Division of Gastroenterology and Hepatology at UC ... its Medical Advisory Board. Joining the board of leading scientists and doctors from ...
(Date:12/5/2018)... ... December 04, 2018 , ... ... companies, announces the placement of Michael Mercer at Karius, Inc. as Chief Commercial ... Mercer will be based at Karius' headquarters in Redwood City, California and report ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... November 13, 2018 , ... , Park Systems, world ... China. With the increasingly growing demand for AFM technology in China, Park Systems has ... by opening an office in Beijing equipped with Park AFM. , The Grand Opening ...
(Date:11/9/2018)... JACKSONVILLE, Fla. (PRWEB) , ... November 08, 2018 ... ... companies in the United States, adopted a machine-learning powered approach to increasing recovery ... was centered around an Artificially Intelligent Collections (AIC) product developed by NLP Logix, ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial ... trial data collection and management. TrialKit ™, an eClinical platform, has incorporated ... can quickly and easily sign in to the app via facial recognition or ...
(Date:11/5/2018)... (PRWEB) , ... November 05, 2018 , ... ... for access to 2Blades’ Transcription Activator Like (TAL) effector code technology for applications ... commercial uses of the technology in plants. Since its discovery in 2009, the efficacy ...
Breaking Biology Technology:
Cached News: